home / stock / arwr / arwr quote
Last: | $22.91 |
---|---|
Change Percent: | -1.5% |
Open: | $22.39 |
Close: | $22.91 |
High: | $24.2199 |
Low: | $22.39 |
Volume: | 2,045,970 |
Last Trade Date Time: | 05/14/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$22.91 | $22.39 | $22.91 | $24.2199 | $22.39 | 2,045,970 | 05-14-2024 |
$22.06 | $22.34 | $22.06 | $22.76 | $21.65 | 1,949,574 | 05-13-2024 |
$22.08 | $25.48 | $22.08 | $25.48 | $21.79 | 2,540,166 | 05-10-2024 |
$24.72 | $25.34 | $24.72 | $25.34 | $24.59 | 707,526 | 05-09-2024 |
$25.22 | $24.73 | $25.22 | $25.27 | $24.3 | 906,027 | 05-08-2024 |
$25 | $25.15 | $25 | $25.38 | $24.86 | 732,018 | 05-07-2024 |
$25.16 | $24.56 | $25.16 | $25.24 | $24.24 | 619,926 | 05-06-2024 |
$24.44 | $25.03 | $24.44 | $25.235 | $24.12 | 630,837 | 05-03-2024 |
$24.13 | $23.46 | $24.13 | $24.3 | $22.73 | 887,727 | 05-02-2024 |
$23.17 | $22.72 | $23.17 | $23.84 | $22.66 | 1,112,142 | 05-01-2024 |
$22.62 | $22.76 | $22.62 | $23.17 | $22.59 | 783,024 | 04-30-2024 |
$23.13 | $22.38 | $23.13 | $23.47 | $22.1534 | 1,168,607 | 04-29-2024 |
$22.12 | $22.12 | $22.12 | $22.36 | $21.72 | 617,126 | 04-26-2024 |
$21.87 | $22.6 | $21.87 | $22.9 | $21.39 | 976,870 | 04-25-2024 |
$23.29 | $23.74 | $23.29 | $23.76 | $22.89 | 813,628 | 04-24-2024 |
$23.78 | $23.95 | $23.78 | $24.68 | $23.67 | 828,233 | 04-23-2024 |
$23.92 | $22.6 | $23.92 | $24.3 | $22.2364 | 1,080,438 | 04-22-2024 |
$22.33 | $22.52 | $22.33 | $22.7599 | $21.75 | 965,833 | 04-19-2024 |
$22.61 | $22.42 | $22.61 | $22.81 | $21.93 | 1,300,210 | 04-18-2024 |
$22.53 | $23.88 | $22.53 | $24.0514 | $22.47 | 1,149,585 | 04-17-2024 |
News, Short Squeeze, Breakout and More Instantly...
Arrowhead Pharmaceuticals Inc. Company Name:
ARWR Stock Symbol:
NASDAQ Market:
2024-05-13 10:30:04 ET Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for ARWR on May 13, 2024 08:34AM ET. The previous analyst recommendation was Equal-Weight. ARWR was trading at $22.39 at issue of the analyst recommendation. The overall analyst consensus : ...
Shares of Diodes Incorporated (NASDAQ:DIOD) fell sharply during Friday's session after the company reported worse-than-expected quarterly fina...
- Conference Call and Webcast Today, May 9, 2024, at 4:30 p.m. ET Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2024 second quarter ended March 31, 2024. The Company is hosting a conference call today, May 9, 2024, at 4:30 p.m. ET to discu...